TORONTO, ON / ACCESSWIRE / January 7, 2025 / CeCors, Inc. (OTC PINK:CEOS) ("CeCors" or the "Company"), along with its wholly-owned subsidiary VETCOMM, a leader in veteran claims benefits, is proud to announce the engagement of Snell & Wilmer LLP.
"We have retained Snell and Wilmer to further strengthen the growth strategy of CeCors coming into the New Year and to bolster corporate compliance and policy for rapidly growing operations of VETCOMM," stated Interm CeCors CEO, Michael Maher. "Engaging with a full-service law firm will assist us in our effort to achieve the highest levels of corporate governance and operational best practices while allowing us access to experienced counsel as the Company takes a step toward laying the groundwork for becoming a fully reporting company with the Securities and Exchange Commission".
This marks a significant milestone for CeCors as it begins a transformative phase focused on operational excellence, transparency, and strategic growth. With the support of Snell & Wilmer, the Company will begin aligning its corporate structure and practices with its long-term vision, positioning itself for greater success and enhancing value for shareholders. This engagement reinforces CeCors' dedication to maintaining the highest standards of compliance, governance, and risk management.
About CeCors, Inc.
CeCors, Inc. (CEOS) is a publicly traded company on the OTC Market, engaging in the acquisition and development of healthcare companies with a focus on military veterans' health and well-being. CEOS has acquired VETCOMM and PsyKey as wholly owned subsidiaries working toward this common goal. VETCOMM aims to bridge the gap between U.S. military veterans and their entitled access to healthcare, vocational benefits, and compensation associated with their military service by utilizing VETCOMM's proprietary tools, education, and resources to guide veterans through the complex process. PsyKey focuses on delivering health and well-being by modifying the habits of daily tea and coffee drinkers with its premium functional mushroom coffee. These are available as K-cups and ground coffee blends infused with high-quality mushrooms such as Lion's Mane, Maitake, Turkey tail, Chaga, and Cordyceps. This innovative solution promotes wellness, boosts immunity, enhances focus, and helps users relax and manage stress. CEOS is committed to the continued research, development, and support of modern-day health solutions while respecting proven traditional remedies from ancient practices.
For further information:
CeCors, Inc.
Website: www.cecorsinc.com
Email: investor@cecorsinc.com
Publicly traded company (OTCMarkets PINK: CEOS)
VETCOMM
Website: www.vetcomm.org
E-mail: info@vetcomm.org
PsyKey Inc.
Website: www.psykeyworld.com
Email: info@psykeyworld.com
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
Contact Information
Rafer Weigel
Communications, VETCOMM
rafer@vetcomm.org
312-914-8690
SOURCE: CeCors, Inc.
View the original press release on accesswire.com
